Table 2.
Validation (N=868) |
Training (N=3476) |
P-value | Overall (N=4344) |
|
---|---|---|---|---|
MI | ||||
Yes | 101 (11.6%) | 400 (11.5%) | 0.963 | 501 (11.5%) |
No | 767 (88.4%) | 3076 (88.5%) | 3843 (88.5%) | |
HF | ||||
Yes | 174 (20.0%) | 699 (20.1%) | 0.875 | 873 (20.1%) |
No | 604 (69.6%) | 2379 (68.4%) | 2983 (68.7%) | |
Missing | 90 (10.4%) | 398 (11.5%) | 488 (11.2%) | |
CAD | ||||
Yes | 192 (22.1%) | 778 (22.4%) | 0.904 | 970 (22.3%) |
No | 676 (77.9%) | 2698 (77.6%) | 3374 (77.7%) | |
Stroke | ||||
Yes | 99 (11.4%) | 476 (13.7%) | 0.0848 | 575 (13.2%) |
No | 769 (88.6%) | 3000 (86.3%) | 3769 (86.8%) | |
Composite CVD | ||||
Yes | 239 (27.5%) | 1060 (30.5%) | 0.0964 | 1299 (29.9%) |
No | 629 (72.5%) | 2416 (69.5%) | 3045 (70.1%) | |
Death by CVD Event | ||||
Yes | 5 (0.6%) | 50 (1.4%) | 0.0624 | 55 (1.3%) |
No | 863 (99.4%) | 3426 (98.6%) | 4289 (98.7%) |